These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33603402)

  • 1. Loss of DAB2IP Contributes to Cell Proliferation and Cisplatin Resistance in Gastric Cancer.
    Wang G; Wang X; Han M; Wang X
    Onco Targets Ther; 2021; 14():979-988. PubMed ID: 33603402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DAB2IP Downregulation Enhances the Proliferation and Metastasis of Human Gastric Cancer Cells by Derepressing the ERK1/2 Pathway.
    Sun L; Yao Y; Lu T; Shang Z; Zhan S; Shi W; Pan G; Zhu X; He S
    Gastroenterol Res Pract; 2018; 2018():2968252. PubMed ID: 29743885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DAB2IP decreases cell growth and migration and increases sensitivity to chemotherapeutic drugs in colorectal cancer.
    Wu G; Xu X; Wan D; Zhou D; Feng Y; Chen J; Peng Z; Fang D; Shi X; Yao H; Chen G; Sun L; Yao Y; Zhou G; Yang Y; He S
    Ann Transl Med; 2021 Aug; 9(16):1317. PubMed ID: 34532454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-92b promotes gastric cancer growth by activating the DAB2IP-mediated PI3K/AKT signalling pathway.
    Ni QF; Zhang Y; Yu JW; Hua RH; Wang QH; Zhu JW
    Cell Prolif; 2020 Jan; 53(1):e12630. PubMed ID: 31713929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. USP14 as a novel prognostic marker promotes cisplatin resistance via Akt/ERK signaling pathways in gastric cancer.
    Fu Y; Ma G; Liu G; Li B; Li H; Hao X; Liu L
    Cancer Med; 2018 Nov; 7(11):5577-5588. PubMed ID: 30296012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daam1 Overexpression Promotes Gastric Cancer Progression and Regulates ERK and AKT Signaling Pathways.
    Zhang Y; Bai X; Zhang Y; Li Y
    Onco Targets Ther; 2021; 14():4609-4619. PubMed ID: 34475767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yes-associated protein enhances proliferation and attenuates sensitivity to cisplatin in human gastric cancer cells.
    Lu T; Sun L; Zhu X
    Biomed Pharmacother; 2018 Sep; 105():1269-1275. PubMed ID: 30021363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA MALAT1 Regulates the Cell Proliferation and Cisplatin Resistance in Gastric Cancer via PI3K/AKT Pathway.
    Dai Q; Zhang T; Li C
    Cancer Manag Res; 2020; 12():1929-1939. PubMed ID: 32214850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yes-Associated Protein Contributes to Cell Proliferation and Migration of Gastric Cancer via Activation of Gli1.
    Han T; Cheng Z; Xu M; Wang X; Wu J; Fang X
    Onco Targets Ther; 2020; 13():10867-10876. PubMed ID: 33149604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cypermethrin inhibits proliferation of Sertoli cells through AR involving DAB2IP/PI3K/AKT signaling pathway in vitro.
    Wang Q; Wang XX; Xie JF; Yao TT; Xu LL; Wang LS; Yu Y; Xu LC
    Toxicol Res (Camb); 2022 Aug; 11(4):583-591. PubMed ID: 36051661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldolase A promotes cell proliferation and cisplatin resistance via the EGFR pathway in gastric cancer.
    Gu M; Jiang B; Li H; Zhu D; Jiang Y; Xu W
    Am J Transl Res; 2022; 14(9):6586-6595. PubMed ID: 36247245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanism of DAB2IP in chemoresistance of prostate cancer cells.
    Wu K; Xie D; Zou Y; Zhang T; Pong RC; Xiao G; Fazli L; Gleave M; He D; Boothman DA; Hsieh JT
    Clin Cancer Res; 2013 Sep; 19(17):4740-9. PubMed ID: 23838317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA UCA1 promotes cisplatin resistance in gastric cancer via recruiting EZH2 and activating PI3K/AKT pathway.
    Dai Q; Zhang T; Pan J; Li C
    J Cancer; 2020; 11(13):3882-3892. PubMed ID: 32328192
    [No Abstract]   [Full Text] [Related]  

  • 14. DNMT3A facilitates colorectal cancer progression via regulating DAB2IP mediated MEK/ERK activation.
    Zhou Y; Yang Z; Zhang H; Li H; Zhang M; Wang H; Zhang M; Qiu P; Zhang R; Liu J
    Biochim Biophys Acta Mol Basis Dis; 2022 Apr; 1868(4):166353. PubMed ID: 35063646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological inhibition of DUSP6 suppresses gastric cancer growth and metastasis and overcomes cisplatin resistance.
    Wu QN; Liao YF; Lu YX; Wang Y; Lu JH; Zeng ZL; Huang QT; Sheng H; Yun JP; Xie D; Ju HQ; Xu RH
    Cancer Lett; 2018 Jan; 412():243-255. PubMed ID: 29050982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNA-556-3p promotes human bladder cancer proliferation, migration and invasion by negatively regulating DAB2IP expression.
    Feng C; Sun P; Hu J; Feng H; Li M; Liu G; Pan Y; Feng Y; Xu Y; Feng K; Feng Y
    Int J Oncol; 2017 Jun; 50(6):2101-2112. PubMed ID: 28440444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of disabled homolog 2-interacting protein contributes to tumor development and proliferation in cutaneous squamous cell carcinoma.
    Yuan SP; Li CX; Qin S; Wen J; Zhang XB; Tian X; Zhu CY; Li T; Huang JP; Zheng XH
    Ann Transl Med; 2020 Sep; 8(18):1131. PubMed ID: 33240980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of DAB2IP results in cell proliferation and invasion and contributes to unfavorable outcomes in bladder cancer.
    Shen YJ; Kong ZL; Wan FN; Wang HK; Bian XJ; Gan HL; Wang CF; Ye DW
    Cancer Sci; 2014 Jun; 105(6):704-12. PubMed ID: 24684735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
    Gu Y; Fei Z; Zhu R
    Anticancer Drugs; 2020 Apr; 31(4):385-393. PubMed ID: 31913198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ATR inhibitor VE-821 increases the sensitivity of gastric cancer cells to cisplatin.
    Su H; Yuan Y; Tang J; Zhang Y; Wu H; Zhang Y; Liang J; Wang L; Zou X; Huang S; Zhang S; Lv Y
    Transl Oncol; 2023 Oct; 36():101743. PubMed ID: 37517142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.